Spermosens AB SPERM.ST
SPERM.ST
Spermosens AB PROGEN.ST
Prostatype Genomics AB (publ) APTA.ST
Aptahem AB (publ) FLUI.ST
Fluicell AB (publ) ODI.ST
ODI Pharma AB CMH.ST
Chordate Medical Holding AB (publ) STABL.ST
Stayble Therapeutics AB (publ) EPIS-B.ST
Episurf Medical AB (publ) QUIA.ST
Quia Pharma AB (publ) S2M.ST
S2Medical AB (publ)
Spermosens AB PROGEN.ST
Prostatype Genomics AB (publ) APTA.ST
Aptahem AB (publ) FLUI.ST
Fluicell AB (publ) ODI.ST
ODI Pharma AB CMH.ST
Chordate Medical Holding AB (publ) STABL.ST
Stayble Therapeutics AB (publ) EPIS-B.ST
Episurf Medical AB (publ) QUIA.ST
Quia Pharma AB (publ) S2M.ST
S2Medical AB (publ)
Performance
| Periode | SPERM.ST | PROGEN.ST | APTA.ST | FLUI.ST | ODI.ST | CMH.ST | STABL.ST | EPIS-B.ST | QUIA.ST | S2M.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -24.44 % | -66.38 % | -24.38 % | 15.97 % | -40.19 % | -9.11 % | -55.02 % | -58.54 % | -77.78 % | -0.83 % |
| YTD | -48.48 % | -93.50 % | -14.93 % | -37.22 % | -48.80 % | -45.06 % | -62.16 % | -64.58 % | -76.47 % | 20.00 % |
| 1Y | -69.09 % | -94.84 % | -22.47 % | -45.24 % | -60.00 % | -87.36 % | -64.60 % | -64.28 % | -85.26 % | -29.41 % |
| 3Y | -99.82 % | -99.90 % | -97.51 % | -98.68 % | -74.40 % | -98.84 % | -94.44 % | -97.30 % | -99.96 % | -98.45 % |
| 5Y | -99.91 % | -99.97 % | -99.29 % | -99.53 % | -74.40 % | -98.86 % | -97.55 % | -97.76 % | -100.00 % | -99.83 % |
| 10Y | -99.91 % | -99.97 % | -99.84 % | -99.74 % | -86.89 % | -98.86 % | -97.15 % | -99.59 % | -100.00 % | -99.91 % |
| Depuis le début | -99.91 % | -99.97 % | -99.85 % | -99.74 % | -86.89 % | -98.86 % | -97.15 % | -99.28 % | -100.00 % | -99.91 % |